Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.78
-0.20 (-2.87%)
At close: Jul 29, 2026, 4:00 PM EDT
6.85
+0.07 (1.03%)
After-hours: Jul 29, 2026, 7:34 PM EDT
Kyntra Bio Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Kyntra Bio stock has a consensus rating of "Buy" and an average price target of $39. The average 1-year stock price forecast is 475.22% higher than the current stock price, while the lowest is $35 (+416.22%) and the highest is $43 (+534.22%).
Price Target: $39 (+475.22%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kyntra Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Feb '26 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $35 | Buy | Initiates | $35 | +416.22% | Jul 6, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $30 | Buy | Initiates | $30 | +342.48% | Jun 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $43 | Buy | Reiterates | $43 | +534.22% | May 12, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 12, 2026 |
Financial Forecast
Revenue This Year
9.95M
from 6.44M
Increased by 54.49%
Revenue Next Year
8.81M
from 9.95M
Decreased by -11.49%
EPS This Year
-13.75
from 45.37
EPS Next Year
-11.44
from -13.75
EPS and Forward PE are based on non-GAAP adjusted numbers.